Sugammadex Sodium is an injectable solution indicated for the reversal of neuromuscular blockade in anesthesia. Medichem is a vertically integrated manufacturer of the product, providing both the API and FDF. Our API plant in Malta offers our customers the competitive advantage of an early launch in countries without patent protection. Medichem´s Sugammadex has been filed globally including in the USA […]
Category: blog
A Policy Roadmap for Medicines Manufacturing Leadership
As part of our work with @Medicines for Europe, we have developed a policy roadmap for medicines manufacturing in Europe. The #COVID19 crisis has reignited this discussion, but with little vision for what needs to be done in practice. Our recommendations set the short/medium/long term timeframe for concrete action at EU level to restore Europe […]
ASIA Q1´20 – Latest Authorizations
Medichem´s DMFs for the Active Pharmaceutical Ingredient of Paroxetine and Rivaroxaban are filed and listed on the CDE website, China – Q1′ 20 Paroxetine is an antidepressant that belongs to the group of drugs called selective serotonin reuptake inhibitors (SSRIs). Rivaroxaban is an anticoagulant medication or blood thinner used to treat and prevent blood […]
Corporate Announcement 14.03.2020
Dear Customer, Like many of you we have been closely following the developments about coronavirus. At Medichem we deeply care about our employees, their families and our communities. We are closely following the recommendations of the world’s leading Health Organizations and their containment objectives. At the same time we strongly believe in our responsibility […]
Q4’19 – Latest Authorizations by the Regulatory Agencies – Asia
Medichem receives the Approval Notice Letter by the Korean Authorities for Apixaban´s Active Pharmaceutical Ingredient – Q4’19 Medichem´s DMF for Quetiapine´s Active Pharmaceutical Ingredient is filed to the NMPA, China – Q4′ 19 […]
Medichem Cares, Sustainable Environment
Sustainable Environment by Medichem […]
Medichem’s R&D and Business Development summit in ESADECREAPOLIS
What could be more inspiring than the ESADECREAPOLIS meeting rooms for Medichem’s R&D and Business Development summit? On July 9th and 10th, the R&D, Business Development and Project Management departments met to discuss Medichem’s innovative and commercial projects. An ideal opportunity to collaborate, fine-tune details and thereof optimize each project. Learning, collaborating, conveying ideas, working […]
USP’s Donor Recognition Program would like to recognize Medichem for its contributions…
“USP’s Donor Recognition Program would like to recognize Medichem for its contributions during the 2018 calendar year” Says Ronald T. Piervincenzi, Ph.D. USP Chief Executive Officer. This program recognizes new and modernized monographs that were published in one of USP’s forums or were posted to USP’s website for comment, as well as those reference […]